Evidence map›Paper›PMID 38488927›Full record

ArticleWorld journal of urology2024

Trends in the use of radiation protection and radiation exposure of European endourologists: a prospective trial from the EULIS-YAU Endourology Group.

Sofia Fontanet Soler, Alejandra Bravo-Balado, Andreas Skolarikos, Christian Seitz, Olivier Traxer, Michele Talso, Eugenio Ventimiglia, Luca Villa, Amelia Pietropaolo, Etienne Xavier Keller and 11 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in World journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 18 institutions in 11 countries.

Sofia Fontanet SolerDepartment of Urology, Fundació Puigvert (IUNA), Autonoma University of Barcelona, Barcelona, Spain. sofia.fontanet@gmail.com.
Alejandra Bravo-BaladoDepartment of Urology, Fundació Puigvert (IUNA), Autonoma University of Barcelona, Barcelona, Spain.
Andreas SkolarikosDepartment of Urology, Sismanogleio Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Christian SeitzDepartment of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Olivier TraxerDepartment of Urology, Tenon Hospital, Hôpitaux Universitaires Paris-EST, Assistance Publique Hôpitaux de Paris, Université Pierre Et Marie Curie Paris 6, Paris, France.
Michele TalsoDepartment of Urology ASST Fatebenefratelli, Sacco University Hospital, Milan, Italy.
Eugenio VentimigliaDepartment of Urology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Luca VillaDepartment of Urology, URI, IRCCS Ospe-Dale San Raffaele, Milan, Italy.
Amelia PietropaoloDepartment of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Etienne Xavier KellerDepartment of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Panagiotis KallidonisDepartment of Urology, University Hospital of Rion, Patras, Greece.
Tarik Emre SenerDepartment of Urology, School of Medicine, Marmara University, Istanbul, Turkey.
Udo NageleDepartment of Urology and Andrology, General Hospital Hall in Tirol, Hall in Tirol, Austria.
Vincent De ConinckDepartment of Urology, AZ Klina, Brasschaat, Belgium.
Zeeshan HameedDepartment of Urology, Kasturba Medical College Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Arman TsaturyanDepartment of Urology, University of Patras, Patras, Greece.
Patrick Juliebø-JonesDepartment of Urology, Haukeland University Hospital, Bergen, Norway.
Ioannis MikoniatisDepartment of Urology, Faculty of Medicine, Aristotle University of Thessaloniki School of Health Sciences, Thessaloniki, Greece.
Oliver WisemanDepartment of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Lazaros TzelvesDepartment of Urology, Sismanogleio Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Esteban EmilianiDepartment of Urology, Fundació Puigvert (IUNA), Autonoma University of Barcelona, Barcelona, Spain.
Istituti di Ricovero e Cura a Carattere Scientifico · ITNational and Kapodistrian University of Athens · GRPuigvert Foundation · ESAddenbrooke's Hospital · GBAristotle University of Thessaloniki · GRAssistance Publique – Hôpitaux de Paris · FRASST Fatebenefratelli Sacco · ITAZ Klina · BEComprehensive Cancer Center Vienna · ATGeneral University Hospital of Patras · GRHaukeland University Hospital · NOKasturba Medical College, Manipal · INMarmara University · TRTirol Kliniken · ATUniversitat de Barcelona · ESUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Patras · GRUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDue to the radiation exposure for the urology staff during endourology, our aim was to evaluate the trends of radiation protection in the operation room by endourologists from European centers and to estimate their annual radiation.

methodsWe conducted a multicenter study involving experienced endourologists from different European centers to evaluate whether the protection and threshold doses recommended by the International Commission on Radiation Protection (ICRP) were being followed. A 36-question survey was completed on the use of fluoroscopy and radiation protection. Annual prospective data from chest, extremities, and eye dosimeters were collected during a 4-year period (2017-2020).

resultsTen endourologists participated. Most surgeons use lead aprons and thyroid shield (9/10 and 10/10), while leaded gloves and caps are rarely used (2/10 both). Six out of ten surgeons wear leaded glasses. There is widespread use of personal chest dosimeters under the apron (9/10), and only 5/10 use a wrist or ring dosimeter and 4 use an eye dosimeter. Two endourologists use the ALARA protocol. The use of ultrasound and fluoroscopy during PCNL puncture was reported by 8 surgeons. The mean number of PCNL and URS per year was 30.9 (SD 19.9) and 147 (SD 151.9). The mean chest radiation was 1.35 mSv per year and 0.007 mSv per procedure. Mean radiation exposure per year in the eyes and extremities was 1.63 and 11.5 mSv.

conclusionsEndourologists did not exceed the threshold doses for radiation exposure to the chest, extremities and lens. Furthermore, the ALARA protocol manages to reduce radiation exposure.

Indexed as

Occupational ExposureRadiation ExposureRadiation ProtectionFluoroscopyHumansProspective StudiesRadiation DosageEndourologyFluoroscopyLead apronLeaded glassesLeaded glovesRadioprotection

Identifiers

PMID38488927
OpenAlexW4392864348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.